These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3298908)

  • 21. Influence of cigarette smoke on antipyrine metabolite formation in rats.
    Nakagawa A; Chiba K; Ishizaki T; Nakamura K
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
    Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
    Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between antipyrine metabolism and acetylation phenotype in health and chronic liver diseases.
    el-Yazigi A; Raines DA; Wahab FA; Sieck JO; Ernst P; Ali H; Dossing M
    J Clin Pharmacol; 1995 Jun; 35(6):615-21. PubMed ID: 7665722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of antipyrine sulphoconjugates in isolated cultured rat hepatocytes.
    Palette C; Dubor F; Rovei V; Advenier C
    Xenobiotica; 1993 Feb; 23(2):181-91. PubMed ID: 8498081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition.
    Buters JT; Zysset T; Reichen J
    Biochem Pharmacol; 1993 Sep; 46(6):983-91. PubMed ID: 8216358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.
    Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD
    Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
    Groen K; Breimer DD; van Bezooijen CF
    Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of norantipyrine sulphate and norantipyrine glucuronide as major metabolites of antipyrine in man and rat.
    Böttcher J; Bässmann H; Schüppel R
    J Pharm Pharmacol; 1984 Jun; 36(6):391-8. PubMed ID: 6146671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
    Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
    J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential induction of antipyrine metabolism by rifampicin.
    Toverud EL; Boobis AR; Brodie MJ; Murray S; Bennett PN; Whitmarsh V; Davies DS
    Eur J Clin Pharmacol; 1981; 21(2):155-60. PubMed ID: 7341283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
    Boobis AR; Brodie MJ; Kahn GC; Toverud EL; Blair IA; Murray S; Davies DS
    Br J Clin Pharmacol; 1981 Dec; 12(6):771-7. PubMed ID: 7340879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on rat liver cytochrome P-450s involved in the metabolism of antipyrine: phenobarbital- and 3-methylcholanthrene-inducible isozymes possessing 4-hydroxylase activity.
    Buppodom P; Koga N; Yamada H; Yoshimura H
    Biochem Pharmacol; 1986 Apr; 35(8):1404-6. PubMed ID: 3964305
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic variation in rates of antipyrine metabolite formation: a study in uninduced twins.
    Penno MB; Dvorchik BH; Vesell ES
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5193-6. PubMed ID: 6946467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct measurement of aminopyrine N-demethylase and antipyrine hydroxylase activities in a monolayer rat primary isolated hepatocyte system.
    Kotake AN
    Biochem Pharmacol; 1981 Sep; 30(17):2473-9. PubMed ID: 21043248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monooxigenase activity in liver diseases (study based on data of antipyrine metabolism)].
    Loginov AS; Bendikov EA; Kel'nia ZhA; Petrakov AV
    Ter Arkh; 1987; 59(2):84-9. PubMed ID: 3576485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of antipyrine and rifampin on the metabolism of diazepam.
    Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
    Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participation of cytochrome P-450 in reductive metabolism of 1-nitropyrene by rat liver microsomes.
    Saito K; Kamataki T; Kato R
    Cancer Res; 1984 Aug; 44(8):3169-73. PubMed ID: 6430544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.